Menu
GeneBe

PTPRN2

protein tyrosine phosphatase receptor type N2, the group of MicroRNA protein coding host genes|Protein tyrosine phosphatases receptor type

Basic information

Region (hg38): 7:157539055-158587823

Links

ENSG00000155093NCBI:5799OMIM:601698HGNC:9677Uniprot:Q92932AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PTPRN2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPRN2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
12
clinvar
16
clinvar
28
missense
55
clinvar
8
clinvar
10
clinvar
73
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
4
non coding
0
Total 0 0 55 20 27

Variants in PTPRN2

This is a list of pathogenic ClinVar variants found in the PTPRN2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-157540717-C-A Benign (Oct 01, 2023)774459
7-157540784-T-C not specified Uncertain significance (Aug 10, 2021)2242842
7-157548964-G-A Benign (Dec 31, 2019)711018
7-157548964-G-C Likely benign (Oct 19, 2018)713474
7-157568929-C-G not specified Uncertain significance (Apr 06, 2024)3311618
7-157571467-C-T not specified Uncertain significance (May 31, 2023)2525779
7-157571487-T-C Likely benign (Jun 05, 2018)742102
7-157576606-G-A Benign (Dec 31, 2019)715613
7-157576675-G-C not specified Uncertain significance (Apr 16, 2024)3311629
7-157576706-G-A not specified Uncertain significance (Apr 12, 2022)2283253
7-157578025-T-C not specified Uncertain significance (Jan 31, 2024)3149541
7-157578031-T-C not specified Uncertain significance (Mar 18, 2024)3311626
7-157578083-C-T not specified Uncertain significance (Jun 11, 2024)2349927
7-157595247-G-T not specified Uncertain significance (Jul 11, 2023)2610213
7-157595289-C-T Likely benign (Jun 05, 2018)741563
7-157595301-C-T Benign (Jun 01, 2018)788297
7-157595307-G-A Likely benign (Oct 10, 2018)765012
7-157621363-G-A Likely benign (Dec 31, 2019)725835
7-157621367-A-G Malignant tumor of prostate Uncertain significance (-)161601
7-157621372-G-GGCCAGTTTCCACCGCCCGTAACCCAGGCTTCCTGCCCCCGGGGCTGGTACGTACAGGTCAGCACA Benign (Dec 31, 2019)789293
7-157621435-C-T Benign (Jun 01, 2018)719217
7-157621454-G-A not specified Uncertain significance (Aug 02, 2021)2340948
7-157621456-T-C Benign (Nov 06, 2018)725594
7-157621475-C-T not specified Uncertain significance (Jun 24, 2022)2411451
7-157656369-G-T Benign (Dec 31, 2019)787541

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PTPRN2protein_codingprotein_codingENST00000389418 231048731
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.39e-71.001257061411257480.000167
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.05736306340.9940.00004236455
Missense in Polyphen182233.280.780182470
Synonymous0.2422922970.9820.00002292106
Loss of Function4.042051.10.3910.00000258569

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004160.000414
Ashkenazi Jewish0.000.00
East Asian0.0001650.000163
Finnish0.00004620.0000462
European (Non-Finnish)0.0001720.000167
Middle Eastern0.0001650.000163
South Asian0.0002670.000229
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in vesicle-mediated secretory processes. Required for normal accumulation of secretory vesicles in hippocampus, pituitary and pancreatic islets. Required for the accumulation of normal levels of insulin-containing vesicles and preventing their degradation. Plays a role in insulin secretion in response to glucose stimuli. Required for normal accumulation of the neurotransmitters norepinephrine, dopamine and serotonin in the brain. In females, but not in males, required for normal accumulation and secretion of pituitary hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (By similarity). Required to maintain normal levels of renin expression and renin release (By similarity). May regulate catalytic active protein-tyrosine phosphatases such as PTPRA through dimerization (By similarity). Has phosphatidylinositol phosphatase activity; the PIPase activity is involved in its ability to regulate insulin secretion. Can dephosphorylate phosphatidylinositol 4,5-biphosphate (PI(4,5)P2), phosphatidylinositol 5-phosphate and phosphatidylinositol 3- phosphate (By similarity). Regulates PI(4,5)P2 level in the plasma membrane and localization of cofilin at the plasma membrane and thus is indirectly involved in regulation of actin dynamics related to cell migration and metastasis; upon hydrolyzation of PI(4,5)P2 cofilin is released from the plasma membrane and acts in the cytoplasm in severing F-actin filaments (PubMed:26620550). {ECO:0000250|UniProtKB:P80560, ECO:0000250|UniProtKB:Q63475, ECO:0000269|PubMed:26620550}.;
Disease
DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus (IDDM). {ECO:0000269|PubMed:8637868, ECO:0000269|PubMed:8798755, ECO:0000269|PubMed:8878534}.;
Pathway
Type I diabetes mellitus - Homo sapiens (human);Neutrophil degranulation;Innate Immune System;Immune System (Consensus)

Recessive Scores

pRec
0.0998

Intolerance Scores

loftool
0.730
rvis_EVS
0.89
rvis_percentile_EVS
89.2

Haploinsufficiency Scores

pHI
0.188
hipred
N
hipred_score
0.361
ghis
0.466

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.780

Gene Damage Prediction

AllRecessiveDominant
MendelianHighMediumMedium
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Ptprn2
Phenotype
homeostasis/metabolism phenotype;

Gene ontology

Biological process
protein dephosphorylation;lipid metabolic process;neurotransmitter secretion;negative regulation of GTPase activity;peptidyl-tyrosine dephosphorylation;insulin secretion involved in cellular response to glucose stimulus;neutrophil degranulation
Cellular component
endoplasmic reticulum lumen;plasma membrane;integral component of plasma membrane;cell junction;integral component of synaptic vesicle membrane;secretory granule membrane;synaptic vesicle membrane;terminal bouton;receptor complex;ficolin-1-rich granule membrane
Molecular function
transmembrane receptor protein tyrosine phosphatase activity